VLP Therapeutics

VLP Therapeutics, LLC was founded in 2013 by seasoned biopharmaceutical veterans with the mission to address unmet global healthcare needs and expand the frontiers of vaccine therapy. Led by CEO Akahata VLPT, the company is currently leveraging VLPT's proprietary platform technology to develop therapeutic vaccines for cancer as well as preventive vaccines for diseases such as malaria and dengue fever.